FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148320771> ?p ?o ?g. }

• W2148320771 endingPage "408" @default.
• W2148320771 startingPage "401" @default.
• W2148320771 abstract "Effects of single and repeated doses of nilotinib on the pharmacokinetics of midazolam, a cytochrome P450 3A (CYP3A) substrate, were assessed in 2 separate studies. In the single-dose nilotinib study, 18 healthy subjects were randomized to 6 treatment sequences to receive single dose of nilotinib 600 mg, midazolam 4 mg, and coadministration of both in a crossover manner. In the repeated-dose nilotinib study, 19 chronic myeloid leukemia patients took a single dose of midazolam 2 mg on days 1 and 13, and nilotinib 400 mg twice daily from days 2-13. In the single-dose study, the geometric mean ratio of the area under the plasma concentration time curve extrapolated to infinity (AUC(inf)) of midazolam plus nilotinib vs. midazolam was 1.3 (90%CI, 1.2-1.5) and the maximum observed serum concentration (C(max)) was 1.2 (90%CI, 1.0-1.4). In the repeated-dose study, the values for AUC(inf) and C(max) were 2.6 (90%CI, 2.1-3.3) and 2.0 (90%CI, 1.7-2.4), respectively. These results indicate that single-dose and repeated-dose administration of nilotinib results in weak and moderate inhibition of CYP3A, respectively. Therefore, appropriate monitoring and dose adjustment may be needed for drugs that are mainly metabolized by CYP3A, and have narrow therapeutic index, when coadministered with nilotinib." @default.
• W2148320771 created "2016-06-24" @default.
• W2148320771 creator A5012683541 @default.
• W2148320771 creator A5026061232 @default.
• W2148320771 creator A5032476416 @default.
• W2148320771 creator A5048038803 @default.
• W2148320771 creator A5053951611 @default.
• W2148320771 creator A5063103434 @default.
• W2148320771 creator A5070754512 @default.
• W2148320771 creator A5083323619 @default.
• W2148320771 date "2015-02-27" @default.
• W2148320771 modified "2023-10-05" @default.
• W2148320771 title "Inhibitory effect of single and repeated doses of nilotinib on the pharmacokinetics of CYP3A substrate midazolam" @default.
• W2148320771 cites W1736805871 @default.
• W2148320771 cites W1999832647 @default.
• W2148320771 cites W2005106433 @default.
• W2148320771 cites W2020103507 @default.
• W2148320771 cites W2029309243 @default.
• W2148320771 cites W2073587057 @default.
• W2148320771 cites W2093585213 @default.
• W2148320771 cites W2097502628 @default.
• W2148320771 cites W2126367135 @default.
• W2148320771 cites W2126848629 @default.
• W2148320771 cites W2134566943 @default.
• W2148320771 cites W2157421942 @default.
• W2148320771 cites W2158933399 @default.
• W2148320771 cites W2168337309 @default.
• W2148320771 cites W2171188310 @default.
• W2148320771 cites W4246529242 @default.
• W2148320771 cites W4293850900 @default.
• W2148320771 doi "https://doi.org/10.1002/jcph.434" @default.
• W2148320771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25418605" @default.
• W2148320771 hasPublicationYear "2015" @default.
• W2148320771 type Work @default.
• W2148320771 sameAs 2148320771 @default.
• W2148320771 citedByCount "15" @default.
• W2148320771 countsByYear W21483207712017 @default.
• W2148320771 countsByYear W21483207712018 @default.
• W2148320771 countsByYear W21483207712019 @default.
• W2148320771 countsByYear W21483207712020 @default.
• W2148320771 countsByYear W21483207712021 @default.
• W2148320771 countsByYear W21483207712022 @default.
• W2148320771 countsByYear W21483207712023 @default.
• W2148320771 crossrefType "journal-article" @default.
• W2148320771 hasAuthorship W2148320771A5012683541 @default.
• W2148320771 hasAuthorship W2148320771A5026061232 @default.
• W2148320771 hasAuthorship W2148320771A5032476416 @default.
• W2148320771 hasAuthorship W2148320771A5048038803 @default.
• W2148320771 hasAuthorship W2148320771A5053951611 @default.
• W2148320771 hasAuthorship W2148320771A5063103434 @default.
• W2148320771 hasAuthorship W2148320771A5070754512 @default.
• W2148320771 hasAuthorship W2148320771A5083323619 @default.
• W2148320771 hasConcept C112705442 @default.
• W2148320771 hasConcept C11824378 @default.
• W2148320771 hasConcept C126322002 @default.
• W2148320771 hasConcept C142724271 @default.
• W2148320771 hasConcept C19831878 @default.
• W2148320771 hasConcept C204787440 @default.
• W2148320771 hasConcept C27081682 @default.
• W2148320771 hasConcept C2776814716 @default.
• W2148320771 hasConcept C2777413986 @default.
• W2148320771 hasConcept C2777583451 @default.
• W2148320771 hasConcept C2778000748 @default.
• W2148320771 hasConcept C2778729363 @default.
• W2148320771 hasConcept C2780035454 @default.
• W2148320771 hasConcept C526171541 @default.
• W2148320771 hasConcept C62231903 @default.
• W2148320771 hasConcept C71924100 @default.
• W2148320771 hasConcept C87813604 @default.
• W2148320771 hasConcept C98274493 @default.
• W2148320771 hasConceptScore W2148320771C112705442 @default.
• W2148320771 hasConceptScore W2148320771C11824378 @default.
• W2148320771 hasConceptScore W2148320771C126322002 @default.
• W2148320771 hasConceptScore W2148320771C142724271 @default.
• W2148320771 hasConceptScore W2148320771C19831878 @default.
• W2148320771 hasConceptScore W2148320771C204787440 @default.
• W2148320771 hasConceptScore W2148320771C27081682 @default.
• W2148320771 hasConceptScore W2148320771C2776814716 @default.
• W2148320771 hasConceptScore W2148320771C2777413986 @default.
• W2148320771 hasConceptScore W2148320771C2777583451 @default.
• W2148320771 hasConceptScore W2148320771C2778000748 @default.
• W2148320771 hasConceptScore W2148320771C2778729363 @default.
• W2148320771 hasConceptScore W2148320771C2780035454 @default.
• W2148320771 hasConceptScore W2148320771C526171541 @default.
• W2148320771 hasConceptScore W2148320771C62231903 @default.
• W2148320771 hasConceptScore W2148320771C71924100 @default.
• W2148320771 hasConceptScore W2148320771C87813604 @default.
• W2148320771 hasConceptScore W2148320771C98274493 @default.
• W2148320771 hasIssue "4" @default.
• W2148320771 hasLocation W21483207711 @default.
• W2148320771 hasLocation W21483207712 @default.
• W2148320771 hasOpenAccess W2148320771 @default.
• W2148320771 hasPrimaryLocation W21483207711 @default.
• W2148320771 hasRelatedWork W1491964893 @default.
• W2148320771 hasRelatedWork W1928886399 @default.
• W2148320771 hasRelatedWork W2017052894 @default.
• W2148320771 hasRelatedWork W2022544796 @default.
• W2148320771 hasRelatedWork W2132019166 @default.

• next